Medplus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for the drug license of one of its stores located in Maharashtra. The suspension order was issued by the Asst. Commissioner & Licensing authority, Food & Drug Administrations, Ahmednagar, Maharashtra. The drug license for the store situated at Bhandari Colony, Ahmednagar, Maharashtra, has been suspended for a period of ten days. The company received the order on December 19, 2025. The suspension is reportedly due to alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The potential revenue loss due to this suspension is estimated at ₹2.00 lacs. This update is provided in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/CIR/2023/123 dated July 13, 2023, and SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The information will be made available on the company's website and the websites of BSE Limited and the National Stock Exchange of India Ltd.